News · 26 weeks63+100%
2025-12-282026-06-21
Mix3890d
- Insider17(45%)
- SEC Filings11(29%)
- Analyst4(11%)
- Other2(5%)
- Leadership2(5%)
- Earnings2(5%)
Latest news
25 items- ANALYSTOscar Health upgraded by Barclays with a new price targetBarclays upgraded Oscar Health from Equal Weight to Overweight and set a new price target of $35.00
- SECOscar Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Oscar Health, Inc. (0001568651) (Filer)
- INSIDERDirector Lang Laura W was granted 8,475 shares, increasing direct ownership by 11% to 82,840 units (SEC Form 4)4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERDirector Plouffe David was granted 8,475 shares, increasing direct ownership by 7% to 137,121 units (SEC Form 4)4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERDirector Sankaran Sid was granted 8,475 shares, increasing direct ownership by 60% to 22,609 units (SEC Form 4)4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERDirector Gassen William was granted 8,475 shares, increasing direct ownership by 11% to 82,840 units (SEC Form 4)4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERDirector Wittman Vanessa Ames was granted 8,475 shares, increasing direct ownership by 7% to 137,121 units (SEC Form 4)4 - Oscar Health, Inc. (0001568651) (Issuer)
- SECOscar Health Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Oscar Health, Inc. (0001568651) (Filer)
- INSIDERChief Accounting Officer Baltrus Victoria sold $33,417 worth of shares (1,523 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 0.70% to 214,589 units (SEC Form 4) to satisfy tax liability4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERDirector Schlosser Mario sold $748,633 worth of shares (34,120 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 480,866 units (SEC Form 4) to cover withholding tax4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERChief Legal Officer Mcananey Adam sold $216,318 worth of shares (9,859 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 218,096 units (SEC Form 4) (tax withholding)4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERPresident, Oscar Insurance Liang Janet sold $273,716 worth of shares (12,475 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 259,057 units (SEC Form 4) (tax withholding)4 - Oscar Health, Inc. (0001568651) (Issuer)
- INSIDERChief Financial Officer Blackley Richard Scott sold $695,162 worth of shares (31,683 units at $21.94) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,074,977 units (SEC Form 4) (tax withholding)4 - Oscar Health, Inc. (0001568651) (Issuer)
- ANALYSTOscar Health upgraded by Wells Fargo with a new price targetWells Fargo upgraded Oscar Health from Underweight to Equal Weight and set a new price target of $20.00
- SECSEC Form 144 filed by Oscar Health Inc.144 - Oscar Health, Inc. (0001568651) (Subject)
- SECOscar Health Inc. filed SEC Form 8-K: Leadership Update8-K - Oscar Health, Inc. (0001568651) (Filer)
- INSIDERChief Financial Officer Blackley Richard Scott sold $2,753,300 worth of shares (110,000 units at $25.03) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 1,106,660 units (SEC Form 4)4 - Oscar Health, Inc. (0001568651) (Issuer)
- SECSEC Form 144 filed by Oscar Health Inc.144 - Oscar Health, Inc. (0001568651) (Subject)
- INSIDERChief Financial Officer Blackley Richard Scott sold $2,316,031 worth of shares (100,000 units at $23.16) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 1,216,660 units (SEC Form 4)4 - Oscar Health, Inc. (0001568651) (Issuer)
- SECSEC Form 144 filed by Oscar Health Inc.144 - Oscar Health, Inc. (0001568651) (Subject)
- SECSEC Form 10-Q filed by Oscar Health Inc.10-Q - Oscar Health, Inc. (0001568651) (Filer)
- ANALYSTWolfe Research initiated coverage on Oscar HealthWolfe Research initiated coverage of Oscar Health with a rating of Peer Perform
- SECOscar Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Oscar Health, Inc. (0001568651) (Filer)
- PROscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 GuidanceOscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the first quarter ended March 31, 2026. "Oscar Health drove solid first-quarter performance with significant year-over-year improvements across our core metrics," said Mark Bertolini, CEO of Oscar Health. "We are reaffirming our guidance and remain on track to significantly expand margins and achieve meaningful profitability in 2026. Consumers expect to shop for healthcare like everyday products – on choice, price, and value. Oscar's exceptional technology, lifestyle products, and member experience deliver exactly that. The workforce is shifting, the individual market is resilient, and Osca
- SECSEC Form DEFA14A filed by Oscar Health Inc.DEFA14A - Oscar Health, Inc. (0001568651) (Filer)
OSCR FAQ
7 questionsWhat does Oscar Health Inc. do?
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a full stack technology platform. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was founded in 2012 and is headquartered in New York, New York.Where does OSCR stock trade?
Oscar Health Inc. (OSCR) is listed on NYSE.What sector and industry is OSCR in?
Oscar Health Inc. operates in the Health Care sector, Medical Specialities industry.When did Oscar Health Inc. go public?
Oscar Health Inc. (OSCR) completed its IPO in 2021.What are analysts saying about OSCR?
Oscar Health Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Overweight with a $3500.00 price target on 2026-06-10. Recent price targets range from $1600.00 to $3500.00.What companies are similar to OSCR?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare OSCR side-by-side with any of them on Quantisnow.How can I track OSCR on Quantisnow?
Quantisnow aggregates Oscar Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OSCR to receive live email and push alerts on every new disclosure.